Methylmalonic Acid Excretion in Vitamin B12 Deficiency
Authors:
- 1 November 1966
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 12 (6) , 704-711
Abstract
Methylmalonic acid was first isolated from pooled human urine in 1957 by Thomas and Stalder and convincing evidence has since been obtained to show that in man the isomerization of l‐methylmalonyl‐Co A to succinyl‐Co A is dependent on the B12 coenzyme dimethylbenzimidazolyl cobamide (White, 1962). Indeed, Cannata, Focesi, Mazumder, Warner and Ochoa (1965) showed recently that l‐methylmalonyl‐Co A mutase bears two molecules of cobamide coenzyme firmly attached to its molecule. In a series of 30 patients Cox and White (1962) detected excessive methylmalonic acid in the urine of all patients with serum vitamin B12 levels below 140 pg./ml., their lower limit of normal. Patients with normal serum B12 levels excreted up to 4 mg. of methylmalonic acid in 24 hours. Their series included six patients who were treated with intramuscular hydroxocobalamin (1000 μg.). In five of these, excretion fell to normal within 3 days, and on the fifth day after injection in the sixth patient. Barness, Young, Mellman, Khan and Williams (1963) reported one vitamin B12 deficient patient in whom the urinary excretion of methylmalonic acid reached 500 mg. in 24 hours. Recently Khan, Williams, Barness, Young, Shafer, Vivacqua and Beaupre (1965) have described seven out of nine patients with pernicious anaemia in whom methylmalonic acid excretion persisted for some months after the institution of B12 therapy. This occurred despite full clinical and haematological remissions and in four patients, normal serum vitamin B12 levels.The present study was undertaken to determine the value of urinary methylmalonic acid excretion as a screening test for vitamin B12 deficiency. The estimation of methylmalonic acid was carried out by a rapid thin layer chromatographic technique, suitable for routine laboratory use. Normal controls and patients suffering from general haematological and medical disorders were screened as well as patients suffering from megaloblastic anaemia. In several patients the excretion of methylmalonic acid was followed for a short period after B12 therapy.Keywords
This publication has 12 references indexed in Scilit:
- Metabolism of Propionic Acid in Animal TissuesJournal of Biological Chemistry, 1965
- Methylmalonate Excretion in a Patient with Pernicious AnemiaNew England Journal of Medicine, 1963
- METHYLMALONIC ACID EXCRETION: AN INDEX OF VITAMIN-B12 DEFICIENCYThe Lancet, 1962
- Studies on the folic acid activity of human serumJournal of Clinical Pathology, 1961
- Urinary Excretion of Beta-Aminoisobutyric Acid (BAIBA) in Leukemia and Polycythemia VeraActa Haematologica, 1961
- THE OCCURRENCE OF β-AMINO-ISOBUTYRIC ACID IN THE URINE OF PATIENTS WITH THALASSEMIA MAJORAustralian Journal of Experimental Biology and Medical Science, 1960
- A metabolic investigation of urinary β-aminoisobutyric acid excretion in manArchives of Biochemistry and Biophysics, 1959
- Isolierung von Methylmalonsäure aus Normalem Menschlichem HarnEuropean Journal of Inorganic Chemistry, 1957
- Urinary excretion of β-aminoisobutyric acid after administration of thymine and nitrogen mustardClinica Chimica Acta, 1957
- A Sugar‐Containing Basal Medium for Vitamin B12‐Assay with Euglena; Application to Body Fluids*The Journal of Protozoology, 1956